650 related articles for article (PubMed ID: 26230845)
1. Microenvironmental Modulation of Decorin and Lumican in Temozolomide-Resistant Glioblastoma and Neuroblastoma Cancer Stem-Like Cells.
Farace C; Oliver JA; Melguizo C; Alvarez P; Bandiera P; Rama AR; Malaguarnera G; Ortiz R; Madeddu R; Prados J
PLoS One; 2015; 10(7):e0134111. PubMed ID: 26230845
[TBL] [Abstract][Full Text] [Related]
2. Small Leucine Rich Proteoglycans (decorin, biglycan and lumican) in cancer.
Appunni S; Anand V; Khandelwal M; Gupta N; Rubens M; Sharma A
Clin Chim Acta; 2019 Apr; 491():1-7. PubMed ID: 30629950
[TBL] [Abstract][Full Text] [Related]
3. Lumican deficiency results in cardiomyocyte hypertrophy with altered collagen assembly.
Dupuis LE; Berger MG; Feldman S; Doucette L; Fowlkes V; Chakravarti S; Thibaudeau S; Alcala NE; Bradshaw AD; Kern CB
J Mol Cell Cardiol; 2015 Jul; 84():70-80. PubMed ID: 25886697
[TBL] [Abstract][Full Text] [Related]
4. Novel regulatory roles of small leucine-rich proteoglycans in remodeling of the uterine cervix in pregnancy.
Colon-Caraballo M; Lee N; Nallasamy S; Myers K; Hudson D; Iozzo RV; Mahendroo M
Matrix Biol; 2022 Jan; 105():53-71. PubMed ID: 34863915
[TBL] [Abstract][Full Text] [Related]
5. Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma.
William D; Walther M; Schneider B; Linnebacher M; Classen CF
PLoS One; 2018; 13(1):e0191511. PubMed ID: 29352318
[TBL] [Abstract][Full Text] [Related]
6. Distinctive localization and function for lumican, fibromodulin and decorin to regulate collagen fibril organization in periodontal tissues.
Matheson S; Larjava H; Häkkinen L
J Periodontal Res; 2005 Aug; 40(4):312-24. PubMed ID: 15966909
[TBL] [Abstract][Full Text] [Related]
7. Colocalization of the collagen-binding proteoglycans decorin, biglycan, fibromodulin and lumican with different cells in human gingiva.
Alimohamad H; Habijanac T; Larjava H; Häkkinen L
J Periodontal Res; 2005 Feb; 40(1):73-86. PubMed ID: 15613083
[TBL] [Abstract][Full Text] [Related]
8. Small leucine-rich proteoglycans in kidney disease.
Schaefer L
J Am Soc Nephrol; 2011 Jul; 22(7):1200-7. PubMed ID: 21719787
[TBL] [Abstract][Full Text] [Related]
9. Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea.
Vij N; Roberts L; Joyce S; Chakravarti S
Exp Eye Res; 2004 May; 78(5):957-71. PubMed ID: 15051477
[TBL] [Abstract][Full Text] [Related]
10. Role of the small leucine-rich proteoglycan (SLRP) family in pathological lesions and cancer cell growth.
Naito Z
J Nippon Med Sch; 2005 Jun; 72(3):137-45. PubMed ID: 16046829
[TBL] [Abstract][Full Text] [Related]
11. The role of SLRP-proteoglycans in osteosarcoma pathogenesis.
Nikitovic D; Berdiaki K; Chalkiadaki G; Karamanos N; Tzanakakis G
Connect Tissue Res; 2008; 49(3):235-8. PubMed ID: 18661350
[TBL] [Abstract][Full Text] [Related]
12. The small leucine-rich proteoglycan lumican inhibits melanoma progression.
Vuillermoz B; Khoruzhenko A; D'Onofrio MF; Ramont L; Venteo L; Perreau C; Antonicelli F; Maquart FX; Wegrowski Y
Exp Cell Res; 2004 Jun; 296(2):294-306. PubMed ID: 15149859
[TBL] [Abstract][Full Text] [Related]
13. Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.
Daniele S; Zappelli E; Natali L; Martini C; Trincavelli ML
Cell Death Dis; 2014 Nov; 5(11):e1539. PubMed ID: 25429616
[TBL] [Abstract][Full Text] [Related]
14. Biomimetic brain tumor niche regulates glioblastoma cells towards a cancer stem cell phenotype.
Liu YC; Lee IC; Chen PY
J Neurooncol; 2018 May; 137(3):511-522. PubMed ID: 29357090
[TBL] [Abstract][Full Text] [Related]
15. YB-1 dependent oncolytic adenovirus efficiently inhibits tumor growth of glioma cancer stem like cells.
Mantwill K; Naumann U; Seznec J; Girbinger V; Lage H; Surowiak P; Beier D; Mittelbronn M; Schlegel J; Holm PS
J Transl Med; 2013 Sep; 11():216. PubMed ID: 24044901
[TBL] [Abstract][Full Text] [Related]
16. Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma.
Brézillon S; Venteo L; Ramont L; D'Onofrio MF; Perreau C; Pluot M; Maquart FX; Wegrowski Y
Clin Exp Dermatol; 2007 Jul; 32(4):405-16. PubMed ID: 17490399
[TBL] [Abstract][Full Text] [Related]
17. Side population is not necessary or sufficient for a cancer stem cell phenotype in glioblastoma multiforme.
Broadley KW; Hunn MK; Farrand KJ; Price KM; Grasso C; Miller RJ; Hermans IF; McConnell MJ
Stem Cells; 2011 Mar; 29(3):452-61. PubMed ID: 21425408
[TBL] [Abstract][Full Text] [Related]
18. Dedifferentiation of patient-derived glioblastoma multiforme cell lines results in a cancer stem cell-like state with mitogen-independent growth.
Olmez I; Shen W; McDonald H; Ozpolat B
J Cell Mol Med; 2015 Jun; 19(6):1262-72. PubMed ID: 25787115
[TBL] [Abstract][Full Text] [Related]
19. Chondroitin sulfate content and decorin expression in glioblastoma are associated with proliferative activity of glioma cells and disease prognosis.
Tsidulko AY; Kazanskaya GM; Volkov AM; Suhovskih AV; Kiselev RS; Kobozev VV; Gaytan AS; Krivoshapkin AL; Aidagulova SV; Grigorieva EV
Cell Tissue Res; 2020 Jan; 379(1):147-155. PubMed ID: 31773303
[TBL] [Abstract][Full Text] [Related]
20. Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.
Ishiwata T; Yamamoto T; Kawahara K; Kawamoto Y; Matsuda Y; Ishiwata S; Naito Z
Exp Mol Pathol; 2010 Jun; 88(3):363-70. PubMed ID: 20138170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
